Hamid Ghandehari, PhD

Languages spoken: English

Academic Information

Departments Primary - , Adjunct - Surgery

Divisions:

Academic Office Information

hamid.ghandehari@pharm.utah.edu

Research Interests

  • Nanotechnology
  • Nanotubes
  • Self-assembled super intelligent nanoparticulates for sensitive and resistant tumor targeting
  • Drug Delivery Systems
  • Polymeric drug delivery systems
  • Targeted Drug Delivery Systems
  • Targeting mechanisms to enhance drug delivery and efficacy

Hamid Ghandehari, PhD, is a professor in the Department of Pharmaceutics, Pharmaceutical Chemistry, and Bioengineering at the University of Utah, and a member of the Experimental Therapeutics Program at Huntsman Cancer Institute. Ghandehari is also a faculty member with the Utah Science Technology and Research Initiative (USTAR) at the University of Utah.

Ghandehari studies new ways to deliver targeted cancer therapies. He researches the design of polymers for targeted delivery of drugs to tumors. He is the co-founder and co-director of the Nano Institute of Utah. A major focus of the Nano Institute is collaboration on the University of Utah campus and beyond to advance the growing field of cancer nanotechnology.

Ghandehari earned both a bachelor's degree and PhD from the University of Utah.

Education History

Doctoral Training University of Utah
 PhD
University of Utah
 BS

Selected Publications

Patent

  1. Line B, Van Echo D, Kennedy A, Ghandehari H, Nan A (2005). Microparticles for Microarterial Imaging and Radiotherapy. U.S. Patent No. WO 2005/061009 A2. Washington, D.C.:U.S. Patent and Trademark Office.